Response to 'Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC' by Yang et al

J Immunother Cancer. 2023 Mar;11(3):e006648. doi: 10.1136/jitc-2022-006648.

Authors

Kun Li¹, Yunfei Qin², Linsen Ye³

Affiliations

¹ Department of Hepatic Surgery and Liver Transplantation Center, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
² Department of Biotherapy Center, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
³ Department of Hepatic Surgery and Liver Transplantation Center, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China ye_linsen@163.com.

No abstract available

Keywords: Cytokines; Drug Therapy, Combination; Immunity, Innate; Immunotherapy; Liver Neoplasms.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies
Carcinoma, Hepatocellular* / drug therapy
Humans
Hyperbaric Oxygenation*
Liver Neoplasms* / drug therapy
Oxygen
Programmed Cell Death 1 Receptor
Radiation-Sensitizing Agents*
Teniposide

Substances

Programmed Cell Death 1 Receptor
Teniposide
Antibodies
Oxygen
Radiation-Sensitizing Agents